IMProGlyco is a European Innovation Council-funded project to establish robust protocols for site-directed mutagenesis of glycans in mammalian cells.
The project is a collaboration between the University of Leeds, the University of York, BOKU University (Vienna), Oslo Metropolitan University, Oslo University Hospital, GlycoSeLect, the Centre for Process Innovation, and HUN-REN TTK.
The project is funded through the EIC Pathfinder Open scheme (101186774 – IMProGlyco).
